BITUB 100mg / ml injectible solution medication leaflet

J04AC01 isoniazid • Antiinfectives for systemic use | Drugs for treatment of tuberculosis | Hydrazides

Isoniazid is an antibiotic used for the treatment and prevention of tuberculosis. It works by inhibiting the synthesis of the cell wall of Mycobacterium tuberculosis, thereby killing the microorganism.

The medication is taken orally, usually once daily, as directed by a doctor. It is important to complete the treatment duration to prevent the development of bacterial resistance.

Side effects may include nausea, vomiting, peripheral neuropathy, or elevated liver enzymes. In rare cases, severe hepatitis or allergic reactions may occur.

Isoniazid is not recommended for patients with severe hepatic impairment or hypersensitivity to this medication.

General data about BITUB 100mg / ml

Substance: isoniazid

Date of last drug list: 01-12-2020

Commercial code: W60594001

Concentration: 100mg / ml

Pharmaceutical form: injectible solution

Quantity: 10

Product type: original

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: YURIA-PHARM LTD. - UCRAINA

Holder: CN UNIFARM S.A. - ROMANIA

Number: 406/2019/01

Shelf life: 1.5 years

Pharmaceutical forms available for isoniazid

Concentrations available for isoniazid

100mg, 100mg/5ml, 100mg/ml, 300mg, 500mg/10ml